Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Four Biomedical Data Scientists Join Karmanos to Advance Cancer Research

The  Barbara Ann Karmanos Cancer Institute  is pleased to welcome four doctoral-level biomedical data scientists who have joined as memb...

Read More

New Imaging Probe Helps Track, Possibly Treat, Prostate Cancer Before Resistance to Treatment Develops

Researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) have developed a chemical imaging probe that resists the...

Read More

Miracle Five-Time Cancer Survivor Saved by Protons

Cancer has darkened Donna Ross’ door five times, and it all started with a lump in her left breast. “The cancer had spread to my lymph nodes,” Don...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now